TAM
KYNB

Tocqueville Asset Management’s Kyntra Bio KYNB Stock Holding History

Tocqueville Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,000
Closed -$2.69M – 809
2017
Q3 		$2.69M Sell
2,000
-1,000
-33% -$1.05M 0.03% 409
2017
Q2 		$2.42M Hold
3,000
– – 0.03% 403
2017
Q1 		$1.85M Sell
3,000
-443
-13% -$270K 0.02% 428
2016
Q4 		$1.84M Buy
3,443
+1,200
+53% +$599K 0.02% 418
2016
Q3 		$1.16M Hold
2,243
– – 0.01% 489
2016
Q2 		$920K Hold
2,243
– – 0.01% 516
2016
Q1 		$1.19M Buy
2,243
+635
+39% +$316K 0.02% 472
2015
Q4 		$1.21M Buy
1,608
+608
+61% +$403K 0.02% 506
2015
Q3 		$548K Buy
+1,000
New +$606K 0.01% 677

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tocqueville Asset Management's KYNB Position: Q4 2017 in Review

Tocqueville Asset Management sold out of Kyntra Bio (KYNB) in Q4 2017, closing a stake of 2,000 shares — an estimated $2.69M sold.

Tocqueville Asset Management first reported a position in KYNB in Q3 2015 and held it in 9 quarters. The position peaked at $2.69M in Q3 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Tocqueville Asset Management reported no remaining Kyntra Bio position as of Q4 2017 after selling out during the quarter.
  • Tocqueville Asset Management sold 2,000 Kyntra Bio shares in Q4 2017, an estimated $2.69M.
  • Tocqueville Asset Management first reported a position in Kyntra Bio in Q3 2015 and held it in 9 quarters.
  • Tocqueville Asset Management's Kyntra Bio position peaked at $2.69M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Tocqueville Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.